Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GABA Antagonist to Improve Reversal of Anesthesia: a Double Blind Study With High-density EEG Surveillance

NCT04329585 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT04329585
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04329585 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GABA Antagonist to Improve Reversal of Anesthesia: a Double Blind Study With High-density EEG Surveillance
Lead sponsor
National Taiwan University Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
March 25, 2020
Completion date
March 31, 2022
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

colonoscopy, moderate sedation